Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
QuintilesIMS
Mallinckrodt
Argus Health
Accenture
Deloitte
Chinese Patent Office
Cipla
Queensland Health
Federal Trade Commission

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040110

« Back to Dashboard
NDA 040110 describes MEPERIDINE HYDROCHLORIDE, which is a drug marketed by West-ward Pharms Int, Duramed Pharms Barr, Epic Pharma, Intl Medication, Barr, Watson Labs, Sun Pharm Inds Inc, Sun Pharm Inds, Mallinckrodt, Wyeth Ayerst, Parke Davis, Baxter Hlthcare, Igi Labs Inc, Abbott, Vintage Pharms, Mikart, Hospira, Icu Medical Inc, and Mallinckrodt Inc, and is included in forty-two NDAs. It is available from nine suppliers. Additional details are available on the MEPERIDINE HYDROCHLORIDE profile page.

The generic ingredient in MEPERIDINE HYDROCHLORIDE is meperidine hydrochloride. There are six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the meperidine hydrochloride profile page.

Summary for NDA: 040110

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details

Pharmacology for NDA: 040110

Mechanism of ActionFull Opioid Agonists

Suppliers and Packaging for NDA: 040110

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MEPERIDINE HYDROCHLORIDE
meperidine hydrochloride
TABLET;ORAL 040110 ANDA West-Ward Pharmaceuticals Corp. 0054-4595 0054-4595-25 100 TABLET in 1 BOTTLE (0054-4595-25)
MEPERIDINE HYDROCHLORIDE
meperidine hydrochloride
TABLET;ORAL 040110 ANDA West-Ward Pharmaceuticals Corp. 0054-4596 0054-4596-25 100 TABLET in 1 BOTTLE (0054-4596-25)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Mar 12, 1997TE:AARLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Mar 12, 1997TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
AstraZeneca
Chubb
Boehringer Ingelheim
Mallinckrodt
Cerilliant
Argus Health
Johnson and Johnson
Harvard Business School
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot